These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8797149)

  • 1. Vasomolol: an ultra short-acting and vasorelaxant vanilloid type beta 1-adrenoceptor antagonist.
    Lin YT; Wu BN; Wu JR; Lo YC; Chen LC; Chen IJ
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):149-57. PubMed ID: 8797149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
    Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
    Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
    Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological effects of an aldehyde type alpha/beta-adrenoceptor blocking agent with vasodilating properties.
    Chiu CC; Lin YT; Tsai CH; Liang JC; Chiang LC; Wu JR; Chen IJ; Yeh JL
    Gen Pharmacol; 2000 Jun; 34(6):391-400. PubMed ID: 11483288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanillylamide-based propanolamine derivative displays alpha/beta-adrenoceptor blocking and vasodilating properties.
    Yeh JL; Wu JR; Chiu CC; Chen YW; Lo YC; Lin YT; Cheng CJ; Chen IJ
    J Cardiovasc Pharmacol; 2002 Jun; 39(6):803-13. PubMed ID: 12021574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities.
    Chiu CC; Wu JR; Lee CH; Liou SF; Dai ZK; Chen IJ; Yeh JL
    Pharmacology; 2004 Mar; 70(3):140-51. PubMed ID: 14752234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaninolol: a new selective beta 1-adrenoceptor antagonist derived from vanillin.
    Wu BN; Hwang TL; Liao CF; Chen IJ
    Biochem Pharmacol; 1994 Jul; 48(1):101-9. PubMed ID: 8043010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoeugenolol: a selective beta1-adrenergic antagonist with tracheal and vascular smooth muscle relaxant properties.
    Lin YT; Wu BN; Horng CF; Huang YC; Hong SJ; Lo YC; Cheng CJ; Chen IJ
    Jpn J Pharmacol; 1999 Jun; 80(2):127-36. PubMed ID: 10440531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eugenodilol: a third-generation beta-adrenoceptor blocker, derived from eugenol, with alpha-adrenoceptor blocking and beta2-adrenoceptor agonist-associated vasorelaxant activities.
    Huang YC; Wu BN; Lin YT; Chen SJ; Chiu CC; Cheng CJ; Chen IJ
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):10-20. PubMed ID: 10413061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new beta-adrenoceptor blocking agent derived from dehydrozingerone.
    Wu BN; Yang CR; Yang JM; Chen IJ
    Gen Pharmacol; 1994 Jul; 25(4):651-9. PubMed ID: 7958725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A highly selective beta1-adrenergic blocker with partial beta2-agonist activity derived from ferulic acid, an active component of Ligusticum wallichii Franch.
    Wu BN; Huang YC; Wu HM; Hong SJ; Chiang LC; Chen IJ
    J Cardiovasc Pharmacol; 1998 May; 31(5):750-7. PubMed ID: 9593075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsinolol: the first beta-adrenoceptor blocker with an associated calcitonin gene-related peptide releasing activity in the heart.
    Chen IJ; Yeh JL; Lo YC; Sheu SH; Lin YT
    Br J Pharmacol; 1996 Sep; 119(1):7-14. PubMed ID: 8872350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilol.
    Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
    Pharmacology; 1989; 39(5):327-36. PubMed ID: 2575762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenoceptor subtypes and the opening of plasmalemmal K(+)-channels in trachealis muscle: electrophysiological and mechanical studies in guinea-pig tissue.
    Cook SJ; Small RC; Berry JL; Chiu P; Downing SJ; Foster RW
    Br J Pharmacol; 1993 Aug; 109(4):1140-8. PubMed ID: 8104643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Labedipinedilol-C: a third-generation dihydropyridine-type calcium channel antagonist displaying K+ channel opening, NO-dependent and adrenergic antagonist activities.
    Yeh JL; Liou SF; Liang JC; Lee CH; Chiu CC; Lin YT; Chen IJ
    J Cardiovasc Pharmacol; 2005 Aug; 46(2):130-40. PubMed ID: 16044023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.
    Uchida Y; Nakamura M; Shimizu S; Shirasawa Y; Fujii M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):132-49. PubMed ID: 6135395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist.
    Tesfamariam B; Allen GT
    Br J Pharmacol; 1994 May; 112(1):55-8. PubMed ID: 7913381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial agonist activity of celiprolol.
    Tung LH; Jackman G; Campbell B; Louis S; Iakovidis D; Louis WJ
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):484-8. PubMed ID: 7681512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular pharmacology of ACC-9089--a novel, ultra-short-acting, beta-adrenergic receptor antagonist.
    Gorczynski RJ; Vuong A
    J Cardiovasc Pharmacol; 1984; 6(4):555-64. PubMed ID: 6206307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.